Request Sample Inquiry
VNA and PACS Market

VNA and PACS Market

VNA and PACS Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

134

Base Year:

2021

Date

Mar - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1389

Segments Covered
  • By Imaging Modality Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Other Imaging Modalities
  • By Type PACS Vender, VNA Software
  • By Mode of Delivery On-Site (Premise), Hybrid, Web/Cloud-based
  • By Usage Model Single Department, Multiple Departments, Multiple Sites
  • By Regions North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: 3,429.10 USD Million
Revenue 2028Revenue 2028: 4728.19 USD Million
Revenue CAGRRevenue CAGR (2022 - 2028): 5.50%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
VNA and PACS Market Share

VNA and PACS Market

Market Synopsis

The global VNA and PACS market is valued at 3,429.10 USD Million in 2021 and is projected to reach a value of 4728.19 USD Million by 2028 at a CAGR of 5.50% over the forecast period.

VNA is a medical archive system that helps manage the life cycle of the medical files stored on it, while PACS is a system that stores images electronically. Both VNA and PACS are important in medical image management that involves the collection, organization of medical images in successive order. To ensure proper image archiving, electronic systems have been developed that not only store imaging data, but also retrieve, share and disseminate medical images. This has led to the increasing adoption of PACS and VNA. The global VNA and PACS market is driven by factors such as increasing investments in the medical imaging industry, rising geriatric imaging volumes, technological improvements in diagnostic imaging modalities, growing adoption of healthcare IT and EHRs, and the rapid spread of big data in the healthcare sector in the next coming years.

VNA and PACS Market Size, 2021 To 2028 (USD 4728.19 Million)

Market Segmentation:

The VNA and PACS market is classified into Imaging Modality, Type, Mode of Delivery and Usage Model. Based on Imaging Modality, the target market is segmented as Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound and Other Imaging Modalities. Based on Mode of Delivery, the target market is categorized as On-Site (Premise), Hybrid and Web/Cloud-based. Based on Type segment, the target market is divided as PACS Vendors and VNA Software. Based on Usage Model segment, the target market is categorized into Single Department, Multiple Departments and Multiple Sites.

Below tree is interactive. You can click the nodes to get more information.

Web/Cloud-based segment accounts for the largest market share in terms of revenue during the forecast period

The web/cloud-based PACS segment is offering new revenue streams to players due to its flexibility to work from remote areas and its easy scalability.

PACS vendors segment holds the largest VNA market share during the forecast period

The PACS vendors segment is expected to capture the largest share of the overall VNA market during the forecast period, owing to traditional PACS, medical imaging modalities, and medical IT companies offering VNA as an extension to their imaging portfolios. Nevertheless, the independent software vendors segment is projected to grow at the highest CAGR over the forecast period due to the emergence of VNA-only companies that focus mainly on providing VNA solutions and advanced enterprise VNA.

Asia Pacific region dominated the VNA and PACS Market during the forecast period

The North America VNA & PACS market is expected to dominate the target market during the forecast period owing to various factors such as better acceptance of advanced technologies, easy access to medical image management solutions, and the presence of many leading medical players. However, the Asia Pacific region is projected to grow at the fastest CAGR throughout the forecast period. Some of the factors driving Asia Pacific VNA & PACS market growth are rising healthcare spending in the region for improving healthcare infrastructure and digital health, the adoption of advanced imaging modalities in the industry, and government initiatives to promote EMR and telehealth.

Competitive Landscape-

Some of the major key players in the VNA and PACS market are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), INFINITT Healthcare Co., Ltd. (South Korea), Hyland Software, Inc. (U.S.), Siemens Healthineers AG (Germany), Agfa-Gevaert Group (U.S.), Mach7 Technologies (U.S.), GE Company (U.S.), FUJIFILM Holdings Corporation (Japan), IBM Corporation (U.S.), BridgeHead Software Ltd. (U.K.), ASPYRA, LLC (U.S.), Sectra AB (Sweden), and Change Healthcare Inc. (U.S.).

VNA and PACS Market is segmented as follows:

Parameter Details
Segments Covered
  • Imaging Modality (Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Other Imaging Modalities)
  • Type (PACS Vender, VNA Software)
  • Mode of Delivery (On-Site (Premise), Hybrid, Web/Cloud-based)
  • Usage Model (Single Department, Multiple Departments, Multiple Sites)
  • Regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Novarad Corporation (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • INFINITT Healthcare Co. Ltd. (South Korea)
  • Siemens Healthineers AG (Germany)
  • Hyland Software Inc. (U.S.)
  • Agfa-Gevaert Group (U.S.)
  • GE Company (U.S.)
  • Mach7 Technologies (U.S.)
  • FUJIFILM Holdings Corporation (Japan)
  • BridgeHead Software Ltd. (U.K.)
  • IBM Corporation (U.S.)
  • Sectra AB (Sweden)
  • ASPYRA
  • LLC (U.S.)
  • and Change Healthcare Inc. (U.S.)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

VNA and PACS Market is tabulated as follows:

VNA and PCAS Market to Reach Valuation of 4728.19 USD Million by 2028; Rising Government Regulations and Positive Guidelines is Impacting the Growth of VNA and PCAS Market
In terms of revenue, the Global VNA and PCAS Market is expected to reach 4728.19 USD Million by 2028, growing at a CAGR of 5.50% from 2022 to 2028. The major driving factor is the presence of favorable government regulations for VNA and PCAS Markets and the increasing demand for standard-based sto...
FAQ
Frequently Asked Question
  • The global VNA and PACS valued at 3,429.10 USD Million in 2020 and is expected to reach 4728.19 USD Million in 2028 growing at a CAGR of 5.50%.

  • The prominent players in the market are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), INFINITT Healthcare Co., Ltd. (South Korea), Siemens Healthineers AG (Germany), Hyland Software, Inc. (U.S.), Agfa-Gevaert Group (U.S.), GE Company (U.S.), Mach7 Technologies (U.S.), FUJIFILM Holdings Corporation (Japan), BridgeHead Software Ltd. (U.K.), IBM Corporation (U.S.), Sectra AB (Sweden), ASPYRA, LLC (U.S.), and Change Healthcare Inc. (U.S.),.

  • The market is project to grow at a CAGR of 5.50% between 2021 and 2028.

  • The driving factors of the VNA and PACS include

    • increasing investments in the medical imaging industry, rising geriatric imaging volumes, technological improvements in diagnostic imaging modalities, growing adoption of healthcare IT and EHRs, and the rapid spread of big data in the healthcare sector

  • North America was the leading regional segment of the VNA and PACS in 2020.